Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Mycobacterium recombinant vaccines.

Labidi AH, Estes RC, David HL, Bollon AP.

Tunis Med. 2001 Feb;79(2):65-81. Review.

PMID:
11414062
2.

Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.

Bosne-David S, Barros V, Verde SC, Portugal C, David HL.

J Antimicrob Chemother. 2000 Sep;46(3):391-5.

PMID:
10980165
3.

An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon.

Sousa AO, Salem JI, Lee FK, Verçosa MC, Cruaud P, Bloom BR, Lagrange PH, David HL.

Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13227-32.

4.

Mycobacteriophage D29 contains an integration system similar to that of the temperate mycobacteriophage L5.

Ribeiro G, Viveiros M, David HL, Costa JV.

Microbiology. 1997 Aug;143 ( Pt 8):2701-8.

PMID:
9274023
5.

Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.

Yamashita JT, Cruaud P, Papa F, Rotta O, David HL.

Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):44-50.

PMID:
8326180
6.

Isolation and characterization of serologically reactive lipooligosaccharides from Mycobacterium tuberculosis.

Papa F, Cruaud P, Luquin M, Thorel MF, Goh KS, David HL.

Res Microbiol. 1993 Feb;144(2):91-9.

PMID:
8337474
7.

Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.

Rastogi N, David HL.

Res Microbiol. 1993 Feb;144(2):133-43. Review. No abstract available.

PMID:
8337471
8.

Comparison of bis-di-octadecylamide of trehalose dicarboxylic acid (BDA.TDA) with glycolipid SL-IV as ELISA antigens for the serodiagnosis of leprosy.

Laszlo A, Cruaud P, Goren MB, Handzel V, Papa F, David HL.

Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):376-81.

PMID:
1282141
11.

Does previous BCG vaccination interfere with the serodiagnosis of tuberculosis using Mycobacterium tuberculosis-specific glycolipid antigens?

Salem JI, Costa MF, Cruaud P, David HL.

Int J Lepr Other Mycobact Dis. 1992 Mar;60(1):87-9. No abstract available.

PMID:
1602200
12.
13.
14.

Cloning and expression of Mycobacterium aurum carotenogenesis genes in Mycobacterium smegmatis.

Houssaini-Iraqui M, Lazraq MH, Clavel-Sérès S, Rastogi N, David HL.

FEMS Microbiol Lett. 1992 Jan 15;69(3):239-44.

PMID:
1555758
15.

Mycobacterial flora of the skin in leprosy.

Fandinho FC, Salem JI, Gontijo-Filho PF, Marója MF, David HL.

Int J Lepr Other Mycobact Dis. 1991 Dec;59(4):569-75.

PMID:
1802939
16.

Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy.

Wayne LG, Good RC, Krichevsky MI, Blacklock Z, David HL, Dawson D, Gross W, Hawkins J, Levy-Frebault VV, McManus C, et al.

Int J Syst Bacteriol. 1991 Oct;41(4):463-72.

PMID:
1742195
17.

Use of the SL-IV and the PGL-Tb1 glycolipid antigens in ELISA for the diagnosis of tuberculosis in AIDS patients.

Berlie HC, Petit JC, David HL.

Zentralbl Bakteriol. 1991 Aug;275(3):351-7.

PMID:
1741916
18.

A new insight into the mycobacterial cell envelope architecture by the localization of antigens in ultrathin sections.

Rastogi N, Hellio R, David HL.

Zentralbl Bakteriol. 1991 Aug;275(3):287-302.

PMID:
1741909
19.

Quantitative relationship between anti-PGL-I-specific antibody levels and the lepromin reaction.

David HL, Maroja M F, Cruaud P.

Int J Lepr Other Mycobact Dis. 1991 Jun;59(2):332-4. No abstract available.

PMID:
2071994
20.

Evaluation of a novel 2,3-diacyl-trehalose-2'-sulphate (SL-IV) antigen for case finding and diagnosis of leprosy and tuberculosis.

Cruaud P, Yamashita JT, Casabona NM, Papa F, David HL.

Res Microbiol. 1990 Jul-Aug;141(6):679-94.

PMID:
2284503
21.

IgG and IgM antibodies immunoreacting with a 2,3-diacyl trehalose-2'-sulphate in sera from leprosy patients.

Cruaud P, Potar MC, David HL, Papa F, Torgal-Garcia J, Maroja F, Orsi-Souza AT.

Zentralbl Bakteriol. 1990 Jun;273(2):209-15.

PMID:
2119181
22.

Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis.

Rastogi N, Goh KS, David HL.

Antimicrob Agents Chemother. 1990 May;34(5):759-64.

23.

Conjugative transfer of a shuttle plasmid from Escherichia coli to Mycobacterium smegmatis [corrected].

Lazraq R, Clavel-Sérès S, David HL, Roulland-Dussoix D.

FEMS Microbiol Lett. 1990 May;57(1-2):135-8. Erratum in: FEMS Microbiol Lett 1990 Aug;58(3):357.

PMID:
2199300
24.

The spectrum of tuberculosis and leprosy: what can be the significance of specific humoral responses?

David HL.

Res Microbiol. 1990 Feb;141(2):197-206; discussion 263-5. Review. No abstract available.

PMID:
2111921
25.

Glycolipids of recent clinical isolates of Mycobacterium tuberculosis: chemical characterization and immunoreactivity.

Daffé M, Papa F, Laszlo A, David HL.

J Gen Microbiol. 1989 Oct;135(10):2759-66.

PMID:
2517299
26.

Antigenicity and specificity of selected glycolipid fractions from Mycobacterium tuberculosis.

Papa F, Cruaud P, David HL.

Res Microbiol. 1989 Oct;140(8):569-78.

PMID:
2516354
27.

Human IgG antibodies immunoreacting with specific sulfolipids from Mycobacterium tuberculosis.

Cruaud P, Berlie C, Torgal Garcia J, Papa F, David HL.

Zentralbl Bakteriol. 1989 Oct;271(4):481-5.

PMID:
2510752
30.

Ability of smooth and rough variants of Mycobacterium avium and M. intracellulare to multiply and survive intracellularly: role of C-mycosides.

Rastogi N, Levy-Frebault V, Blom-Potar MC, David HL.

Zentralbl Bakteriol Mikrobiol Hyg A. 1989 Jan;270(3):345-60.

PMID:
2929188
31.

Isoenzymes profiles in slowly-growing and difficult-to-grow mycobacteria.

Blom-Potar MC, David HL, Rastogi N.

Acta Leprol. 1989;7 Suppl 1:48-9.

PMID:
2548364
32.

Isoenzymes as tools to discriminate various subdivisions in the Mycobacterium fortuitum complex.

Blom-Potar MC, David HL, Rastogi N.

Acta Leprol. 1989;7 Suppl 1:39-43.

PMID:
2548363
33.

Serological specificity of Mycobacterium tuberculosis glycolipids.

Papa F, Laszlo A, David HL, Daffé M.

Acta Leprol. 1989;7 Suppl 1:98-101.

PMID:
2504016
34.

Specificity and antigenicity of mycoside G and other glycolipids from Mycobacterium marinum.

Cruaud P, Papa F, David HL, Daffé M.

Acta Leprol. 1989;7 Suppl 1:94-7.

PMID:
2504015
35.
36.

Serologic and immunocytochemical analysis of the Mycobacterium avium cell envelope.

David HL, Thorel MF, Fréhel C, Rastogi N.

Acta Leprol. 1989;7 Suppl 1:55-8.

PMID:
2504006
37.

Restriction map of mycobacteriophage D29 and its deletion mutant F5.

Lazraq R, Moniz-Pereira J, Clavel-Sérès S, Clément F, David HL.

Acta Leprol. 1989;7 Suppl 1:234-8.

PMID:
2503994
38.

Mode of action of antimycobacterial drugs.

David HL, Laszlo A, Rastogi N.

Acta Leprol. 1989;7 Suppl 1:189-94. Review. No abstract available.

PMID:
2503988
39.

Isolation and characterization of mycobacteria colonizing the healthy skin.

Salem JI, Gontijo Filho P, Lévy-Frébault V, David HL.

Acta Leprol. 1989;7 Suppl 1:18-20. No abstract available.

PMID:
2503984
40.

Comparative intracellular growth of difficult-to-grow and other mycobacteria in a macrophage cell line.

Rastogi N, Blom-Potar MC, David HL.

Acta Leprol. 1989;7 Suppl 1:156-9.

PMID:
2503976
41.

The use of PGL-Tb 1 from M. tuberculosis in the serological diagnosis of tuberculous meningitis: a preliminary report.

Torgal-Garcia J, Papa F, David HL.

Acta Leprol. 1989;7 Suppl 1:136-7. No abstract available.

PMID:
2503971
42.

Detection of antibodies against purified mycobacterial phenolic-glycolipids (PGL's): a sensitive solidphase multiple-antigen-immuno-assay (MAIA).

Roth F, Burkart F, Torgal-Garcia J, David HL.

Acta Leprol. 1989;7 Suppl 1:133-5. No abstract available.

PMID:
2503970
43.
44.

Non-cultivable mycobacteria in ulcers of the skin.

Salem JI, Gadelha AR, Maroja F, David HL.

Acta Leprol. 1989;7 Suppl 1:10-5.

PMID:
2503961
45.

Specificity of Mycobacterium tuberculosis phenolic glycolipid (PGL-Tb1) antiserum.

Papa F, Laszlo A, David HL.

Ann Inst Pasteur Microbiol. 1988 Sep-Oct;139(5):535-45.

PMID:
2472828
46.

Mechanisms of pathogenicity in mycobacteria.

Rastogi N, David HL.

Biochimie. 1988 Aug;70(8):1101-20. Review.

PMID:
3147701
47.

Antibacterial action of amphipathic derivatives of isoniazid against the Mycobacterium avium complex.

Rastogi N, Moreau B, Capmau ML, Goh KS, David HL.

Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Jun;268(4):456-62.

PMID:
3213317
48.

Preliminary evaluation of a Mycobacterium tuberculosis phenolglycolipid antigen in the serologic diagnosis of tuberculosis.

Torgal-Garcia J, David HL, Papa F.

Ann Inst Pasteur Microbiol. 1988 May-Jun;139(3):289-94. No abstract available.

PMID:
3140845
49.

Further studies on colistin (polymyxin E)-induced cell leakage in mycobacteria: Mg++ efflux in Mycobacterium avium and its effects on drug-susceptibility.

Rastogi N, Potar MC, Henrotte JG, Franck G, David HL.

Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Apr;268(2):251-8.

PMID:
3394452
50.

Supplemental Content

Loading ...
Support Center